BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy
Motilal Oswal Report
Dabur India Ltd, one of the leading FMCG companies in India, is also a world leader in Ayurveda with a portfolio of over 250 herbal and ayurvedic products. It operates in key consumer products categories like hair care, oral care, health care, skin care, home care and foods.
The new CEO Mr. Malhotra in Q2FY20, had intuited the need to get back to grow the core healthcare segment, which contributes approximately 30% of sales. The goal is to appeal to the millennial, increase accessibility and drive penetration through sampling and innovation.
Given the current pandemic, Ayurvedic products are witnessing strong traction (expect revenues at 35% of sales in FY21), which is positive for Dabur as the segment is more profitable than the rest of the portfolio. In its home and personal care portfolio where penetration is very high, the aim is to take market share from peers and plug gaps in terms of portfolio/ geography. Further the sales from new launches are targeted to reach approximately 5% of total sales in 2 years (from 2% in FY20).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR